|
End-of-day quote
Nasdaq
2026-10-27
|
5-day change | 1st Jan Change | ||
| 0.4746 USD | +18.92% |
|
+9.05% | -99.39% |
| 10-08 | RBC Raises Price Target on Onconetix to $459 From $450, Keeps Outperform Rating | MT |
| 09-24 | SRX Global Inc. acquired an unknown minority stake in Onconetix, Inc.. | CI |
Company Valuation: Onconetix, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 17.02 | 3.635 | 5.224 | 2.426 |
| Change | - | -78.64% | 43.7% | -53.56% |
| Enterprise Value (EV) 1 | -8.736 | 8.967 | 14.02 | -2.746 |
| Change | - | 202.64% | 56.41% | -119.58% |
| P/E | - | - | - | -0.09x |
| PBR | - | - | - | 0.15x |
| PEG | - | - | - | - |
| Capitalization / Revenue | - | 62,178,226x | 2,069,558x | 2,975,087x |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | 0.66x | -0.57x | -1.9x | 0.43x |
| EV / EBIT | 0.66x | -0.56x | -1.72x | 0.43x |
| EV / FCF | 2.61x | -0.56x | -10.4x | 0.61x |
| FCF Yield | 38.3% | -179% | -9.64% | 164% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | - | -828.1 |
| Distribution rate | - | - | - | - |
| Net sales | - | 0.0585 | 2.524 | 0.8154 |
| EBITDA 1 | -13.17 | -15.84 | -7.4 | -6.33 |
| EBIT 1 | -13.18 | -15.88 | -8.131 | -6.345 |
| Net income 1 | -13.42 | -37.41 | -58.69 | -14.03 |
| Net Debt 1 | -25.75 | 5.331 | 8.801 | -5.172 |
| Reference price 2 | 186,998.5040 | 33,659.7307 | 2,677.5013 | 78.0000 |
| Nbr of stocks (in thousands) | 0.09 | 0.11 | 1.95 | 31.1 |
| Announcement Date | 3/9/23 | 4/11/24 | 6/2/25 | 3/13/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.36M | |
| 37.84x | 13.27x | 28.43x | 0.53% | 1,148B | |
| 39.67x | 6.67x | 18.75x | 1.97% | 652B | |
| 37.4x | 8.39x | 17.35x | 2.4% | 505B | |
| 21.45x | 5.21x | 12.93x | 2.51% | 384B | |
| 102.73x | 5.76x | 24.72x | 2.42% | 348B | |
| 21.89x | 5.76x | 13.88x | 2.85% | 294B | |
| 22.21x | 4.49x | 12.82x | 1.97% | 264B | |
| 28.66x | 7.33x | 13.12x | 2.23% | 244B | |
| -45.79x | 7.11x | 27.55x | 2.07% | 197B | |
| Average | 29.56x | 7.11x | 18.84x | 2.11% | 403.72B | |
| Weighted average by Cap. | 35.29x | 8.40x | 20.64x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONCO Stock
- Valuation Onconetix, Inc.
Select your edition
All financial news and data tailored to specific country editions
